NO20021083L - Pyrazolo[4,3-d]pyrimidiner - Google Patents

Pyrazolo[4,3-d]pyrimidiner

Info

Publication number
NO20021083L
NO20021083L NO20021083A NO20021083A NO20021083L NO 20021083 L NO20021083 L NO 20021083L NO 20021083 A NO20021083 A NO 20021083A NO 20021083 A NO20021083 A NO 20021083A NO 20021083 L NO20021083 L NO 20021083L
Authority
NO
Norway
Prior art keywords
pyrazolo
pyrimidines
phosphodiesterase
inhibition
therapy
Prior art date
Application number
NO20021083A
Other languages
English (en)
Other versions
NO20021083D0 (no
Inventor
Rochus Jonas
Hans-Michael Eggenweiler
Pierre Schelling
Maria Christadler
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20021083D0 publication Critical patent/NO20021083D0/no
Publication of NO20021083L publication Critical patent/NO20021083L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Pyrazolo[4,3-d]pyrimidiner med formel 1 samt deres fysiologisk akseptable salter, hvor R1, R2, R3, R4 Og X har de i krav l angitte betydninger, utviser en fosfodiesterase V-inhibering og kan anvendes til behandling av sykdommer i hjerte-karsystemet og til behandling og/eller terapi av potensforstyrrelser.
NO20021083A 1999-09-06 2002-03-05 Pyrazolo[4,3-d]pyrimidiner NO20021083L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19942474A DE19942474A1 (de) 1999-09-06 1999-09-06 Pyrazolo[4,3-d]pyrimidine
PCT/EP2000/008257 WO2001018004A2 (de) 1999-09-06 2000-08-24 PYRAZOLO[4,3-d]PYRIMIDINE

Publications (2)

Publication Number Publication Date
NO20021083D0 NO20021083D0 (no) 2002-03-05
NO20021083L true NO20021083L (no) 2002-03-05

Family

ID=7920966

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021083A NO20021083L (no) 1999-09-06 2002-03-05 Pyrazolo[4,3-d]pyrimidiner

Country Status (23)

Country Link
US (1) US6777419B1 (no)
EP (1) EP1210349B1 (no)
JP (1) JP4975921B2 (no)
KR (1) KR20020025253A (no)
CN (1) CN1145627C (no)
AR (1) AR025569A1 (no)
AT (1) ATE231866T1 (no)
AU (1) AU773878B2 (no)
BR (1) BR0013781A (no)
CA (1) CA2384037C (no)
CZ (1) CZ294587B6 (no)
DE (2) DE19942474A1 (no)
DK (1) DK1210349T3 (no)
ES (1) ES2189766T3 (no)
HU (1) HUP0202624A3 (no)
MX (1) MXPA02002383A (no)
NO (1) NO20021083L (no)
PL (1) PL353366A1 (no)
PT (1) PT1210349E (no)
RU (1) RU2249594C2 (no)
SK (1) SK3132002A3 (no)
WO (1) WO2001018004A2 (no)
ZA (1) ZA200202653B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10031584A1 (de) 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
WO2002049651A1 (de) * 2000-12-19 2002-06-27 Merck Patent Gmbh Pharmazeutische formulierung enthaltend pyrazolo[4,3-d]pyrimidine und antithrombotica, calcium-antagonisten, prostaglandine oder prostaglandinderivate
DE10103647A1 (de) 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates
DE10148883A1 (de) 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
EP1620437B1 (en) 2003-04-29 2009-06-17 Pfizer Limited 5,7-diaminopyrazolo¬4,3-d pyrimidines useful in the traetment of hypertension
US7572799B2 (en) * 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
GB0327323D0 (en) * 2003-11-24 2003-12-31 Pfizer Ltd Novel pharmaceuticals
CA2562251C (en) * 2004-04-07 2009-04-28 Pfizer Inc. Pyrazolo'4,3-d pyrimidines
EP1881985B1 (en) 2005-05-12 2010-12-29 Pfizer, Inc. Anhydrous crystalline forms of n-ý1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl¨methanesulfonamide
NL2000291C2 (nl) 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
PE20140928A1 (es) * 2011-04-21 2014-08-24 Origenis Gmbh Pirazolo[4,3-d]pirimidinas utiles como inhibidores de cinasas
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
US10034861B2 (en) 2016-07-04 2018-07-31 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
AR113926A1 (es) 2017-12-14 2020-07-01 H Lundbeck As Derivados de 1h-pirazolo[4,3-b]piridinas
RS62551B1 (sr) * 2017-12-14 2021-12-31 H Lundbeck As Kombinovane terapije koje obuhvataju primenu 1h-pirazolo[4,3-b]piridina
EP3728250A1 (en) 2017-12-20 2020-10-28 H. Lundbeck A/S PYRAZOLO[3,4-beta]PYRIDINES AND IMIDAZO[1,5-beta]PYRIDAZINES AS PDE1 INHIBITORS
US10766893B2 (en) * 2017-12-20 2020-09-08 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256650A (en) * 1989-03-29 1993-10-26 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
CA2288910C (en) 1997-04-25 2003-06-24 Pfizer Inc. Pyrazolopyrimidinones for sexual dysfunction
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE10031584A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
DE10060388A1 (de) * 2000-12-05 2002-06-06 Merck Patent Gmbh Verwendung von Pyrazolo [4,3-d]pyrimidinen
DE10103647A1 (de) * 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates

Also Published As

Publication number Publication date
EP1210349B1 (de) 2003-01-29
AU773878B2 (en) 2004-06-10
DK1210349T3 (da) 2003-05-19
RU2249594C2 (ru) 2005-04-10
WO2001018004A2 (de) 2001-03-15
EP1210349A2 (de) 2002-06-05
ES2189766T3 (es) 2003-07-16
AR025569A1 (es) 2002-12-04
KR20020025253A (ko) 2002-04-03
CZ294587B6 (cs) 2005-02-16
MXPA02002383A (es) 2002-09-02
CN1377357A (zh) 2002-10-30
DE19942474A1 (de) 2001-03-15
US6777419B1 (en) 2004-08-17
ZA200202653B (en) 2003-09-23
NO20021083D0 (no) 2002-03-05
CA2384037C (en) 2009-10-13
CA2384037A1 (en) 2001-03-15
PT1210349E (pt) 2003-06-30
BR0013781A (pt) 2002-05-14
WO2001018004A3 (de) 2001-08-09
JP4975921B2 (ja) 2012-07-11
HUP0202624A3 (en) 2004-11-29
ATE231866T1 (de) 2003-02-15
CN1145627C (zh) 2004-04-14
AU7279300A (en) 2001-04-10
PL353366A1 (en) 2003-11-17
SK3132002A3 (en) 2002-07-02
DE50001191D1 (de) 2003-03-06
CZ2002736A3 (cs) 2002-05-15
JP2003508534A (ja) 2003-03-04
HUP0202624A2 (hu) 2002-12-28

Similar Documents

Publication Publication Date Title
NO20021083L (no) Pyrazolo[4,3-d]pyrimidiner
NO20002702L (no) Tienopyrimidiner
GEP20043303B (en) Polycycloalkylpurines as Adenosine Receptor Antagonists
NO984081L (no) Pyrimido[5,4-d]pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremtilling derav
DE69410121D1 (en) Dihydro pyrazolopyrrole
GEP20084528B (en) 5,7-DIAMINOPYRAZOLO [4,3-d] PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY
NO20054208L (no) Nitrogen-substituerte heksahydropyrazino[1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
NO991761L (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
CA2367704A1 (en) Pyrazolobenzodiazepines as cdk2 inhibitors
NO20054085L (no) Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
BG101289A (en) Pyrimido/5,4-d/pyrimidines, medicamentous forms containing them, their application and method for their preparation
TW200504062A (en) Novel pyridopyrazines and the use thereof as kinase inhibitors
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
CA2086434A1 (en) Quinuclidine derivatives
TW200505917A (en) Novel pyridopyrazines and the use thereof as kinase inhibitors
TR200402342T4 (tr) 2-Pirindinil-6,7,8,9- Tetrahidropyrimido[1,2-A] Pirimidin-4-On ve 7-Pirindinil-1,3-Dihydoimidazo[1,2-A]Pirimidin-5(1H) on Türevleri
DE50211929D1 (en) Pyrimidinderivate
MY133785A (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
GEP20043267B (en) Adenosine Receptor Antagonists, Methods of Making and Using the Same
BG105689A (en) Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia
UA42731C2 (uk) Арилалкілтіадіазинони, спосіб їх отримання, фармацевтична композиція, спосіб її отримання, спосіб лікування
NO982863L (no) Nye forbindelser med analgetisk effekt
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20055517L (no) 4-,6-O 7-hydroksyindoler med N-oksidgrupper og anvendelse av disse som terapeutiske midler
DK1025101T3 (da) Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application